Blood Glucose Control in Intensive Care Patients Using the Space GlucoseControl System

• Frequency of hypoglycaemic episodes [ Time Frame: From start of treatment to the last glucose measurement under treatment, typically up to 14 days. ] [ Designated as safety issue: Yes ]
• Adherence to the advice of the SGC system [ Time Frame: From start of treatment to the last glucose measurement under treatment, typically up to 14 days. ] [ Designated as safety issue: No ]
• Blood glucose measurement interval [ Time Frame: From start of treatment to the last glucose measurement under treatment, typically up to 14 days. ] [ Designated as safety issue: No ]

Glucose metabolism is impaired in many critically ill patients and is often aggravated by parenteral feeding, infections and/or pre-existent diabetes.Therefore insulin infusion protocols, which are based on frequent bedside glucose monitoring, have been implemented on most critical care units. Despite extensive efforts of the intensive care unit staff difficulties were experienced in achieving efficient and safe glucose control. Several barriers to the implementation of glycemic control have been identified. Most importantly, there is concern about increased frequency of severe hypoglycemic episodes. To overcome these problems Space GlucoseControl was developed as a decision support system which helps to achieve safe and reliable blood glucose control in the desired ranges (4.4 - 6.1 mmol/l or 4.4 - 8.3 mmol/l).

The objective of this non-interventional study is to gain additional information on the performance of the Space GlucoseControl system for glycaemic control in ICU patients when used in routine clinical practice.

adult patients

Inclusion:

• Intensive care patients who require blood glucose control by intravenous application of insulin

Exclusion:

• All contraindication of intravenous insulin therapy